Evidence map›Paper›PMID 35407213›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Formulation and In Vitro Efficacy Assessment of

Mohammad Firoznezhad, Ines Castangia, Carlo Ignazio Giovanni Tuberoso, Filippo Cottiglia, Francesca Marongiu, Marco Porceddu, Iris Usach, Elvira Escribano-Ferrer, Maria Letizia Manca, Maria Manconi

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Liposomal Delivery of a BiotechnologicalAntioxidants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Mohammad FiroznezhadDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.
Ines CastangiaDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-3100-8107
Carlo Ignazio Giovanni TuberosoDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-8097-3333
Filippo CottigliaDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.
Francesca MarongiuDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.
Marco PorcedduDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-3180-9000
Iris UsachDepartment of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, 46100 Valencia, Spain.ORCID 0000-0002-5786-5668
Elvira Escribano-FerrerBiopharmaceutics and Pharmacokinetics Unit, Institute for Nanoscience and Nanotechnology, University of Barcelona, 08028 Barcelona, Spain.
Maria Letizia MancaDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-3787-257X
Maria ManconiDepartment of Scienze della Vita e dell'Ambiente, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0003-4818-2344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extract of

Indexed as

antioxidant activityfibroblastsglycerosomesMediterranean plantphospholipid vesiclesplant extractscratch assaytransfersomes

Identifiers

PMID35407213
PMCPMC9000414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.